Emotion regulation across psychiatric disorders
CNS Spectr. 2024 May 2:1-15. doi: 10.1017/S1092852924000270. Online ahead of print.NO ABSTRACTPMID:38695189 | DOI:10.1017/S1092852924000270 (Source: CNS Spectrums)
Source: CNS Spectrums - May 2, 2024 Category: Neurology Authors: Ibrahim H Aslan Lucy Dorey Jon E Grant Samuel R Chamberlain Source Type: research
Polysomnographic parameters associated with cognitive function in patients with major depression and insomnia
CNS Spectr. 2024 Apr 30:1-28. doi: 10.1017/S1092852924000257. Online ahead of print.NO ABSTRACTPMID:38685584 | DOI:10.1017/S1092852924000257 (Source: CNS Spectrums)
Source: CNS Spectrums - April 30, 2024 Category: Neurology Authors: Carlos Olivera-L ópez Alejandro Jim énez-Genchi David Ortega-Robles Matilde Valencia-Flores Selene Cansino Judith Salvador-Cruz Source Type: research
Towards the correlates of Stressful Life Events as precipitants of OCD: a systematic review and metanalysis
CNS Spectr. 2024 Apr 30:1-30. doi: 10.1017/S1092852924000269. Online ahead of print.NO ABSTRACTPMID:38685590 | DOI:10.1017/S1092852924000269 (Source: CNS Spectrums)
Source: CNS Spectrums - April 30, 2024 Category: Neurology Authors: Ver ônica Hühne Samara Dos Santos-Ribeiro Maria Eduarda Moreira-de-Oliveira Gabriela Bezerra de Menezes Leo Fontenelle Source Type: research
Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorder
CNS Spectr. 2024 Apr 30:1-32. doi: 10.1017/S1092852924000245. Online ahead of print.NO ABSTRACTPMID:38685594 | DOI:10.1017/S1092852924000245 (Source: CNS Spectrums)
Source: CNS Spectrums - April 30, 2024 Category: Neurology Authors: Roger McIntyre Ofer Agid Egbert Biesheuvel Pradeep Purushottamahanti Venkata Satya Sai Minnikanti Source Type: research
Polysomnographic parameters associated with cognitive function in patients with major depression and insomnia
CNS Spectr. 2024 Apr 30:1-28. doi: 10.1017/S1092852924000257. Online ahead of print.NO ABSTRACTPMID:38685584 | DOI:10.1017/S1092852924000257 (Source: CNS Spectrums)
Source: CNS Spectrums - April 30, 2024 Category: Neurology Authors: Carlos Olivera-L ópez Alejandro Jim énez-Genchi David Ortega-Robles Matilde Valencia-Flores Selene Cansino Judith Salvador-Cruz Source Type: research
Towards the correlates of Stressful Life Events as precipitants of OCD: a systematic review and metanalysis
CNS Spectr. 2024 Apr 30:1-30. doi: 10.1017/S1092852924000269. Online ahead of print.NO ABSTRACTPMID:38685590 | DOI:10.1017/S1092852924000269 (Source: CNS Spectrums)
Source: CNS Spectrums - April 30, 2024 Category: Neurology Authors: Ver ônica Hühne Samara Dos Santos-Ribeiro Maria Eduarda Moreira-de-Oliveira Gabriela Bezerra de Menezes Leo Fontenelle Source Type: research
Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorder
CNS Spectr. 2024 Apr 30:1-32. doi: 10.1017/S1092852924000245. Online ahead of print.NO ABSTRACTPMID:38685594 | DOI:10.1017/S1092852924000245 (Source: CNS Spectrums)
Source: CNS Spectrums - April 30, 2024 Category: Neurology Authors: Roger McIntyre Ofer Agid Egbert Biesheuvel Pradeep Purushottamahanti Venkata Satya Sai Minnikanti Source Type: research
Comparative Efficacy of Akathisia Treatments: A Network Meta-Analysis
CNS Spectr. 2024 Apr 29:1-28. doi: 10.1017/S1092852924000233. Online ahead of print.NO ABSTRACTPMID:38682452 | DOI:10.1017/S1092852924000233 (Source: CNS Spectrums)
Source: CNS Spectrums - April 29, 2024 Category: Neurology Authors: Luca Gambol ò Dario Bottignole Marta D'Angelo Lorenzo Bellini Giuseppe Stirparo Source Type: research
Comparative Efficacy of Akathisia Treatments: A Network Meta-Analysis
CNS Spectr. 2024 Apr 29:1-28. doi: 10.1017/S1092852924000233. Online ahead of print.NO ABSTRACTPMID:38682452 | DOI:10.1017/S1092852924000233 (Source: CNS Spectrums)
Source: CNS Spectrums - April 29, 2024 Category: Neurology Authors: Luca Gambol ò Dario Bottignole Marta D'Angelo Lorenzo Bellini Giuseppe Stirparo Source Type: research
Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery- Åsberg Depression Rating Scale and the 9-item Patient Health Questionnaire
CONCLUSIONS: In adults with TRD, ESK + OAD significantly improved severity of depressive symptoms, and more patients achieved clinically meaningful changes in depressive symptoms based on PHQ-9, versus OAD + PBO. PHQ-9 outcomes were consistent with those of clinician-rated MADRS.TRIAL REGISTRATION: ClinicalTrials.gov: NCT02417064, NCT02418585, NCT02493868.PMID:38557430 | DOI:10.1017/S1092852924000105 (Source: CNS Spectrums)
Source: CNS Spectrums - April 1, 2024 Category: Neurology Authors: Jennifer Kern Sliwa Ronaldo R Naranjo Ibrahim Turkoz Mary Pat Petrillo Patricia Cabrera Madhukar Trivedi Source Type: research
Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery- Åsberg Depression Rating Scale and the 9-item Patient Health Questionnaire
CONCLUSIONS: In adults with TRD, ESK + OAD significantly improved severity of depressive symptoms, and more patients achieved clinically meaningful changes in depressive symptoms based on PHQ-9, versus OAD + PBO. PHQ-9 outcomes were consistent with those of clinician-rated MADRS.TRIAL REGISTRATION: ClinicalTrials.gov: NCT02417064, NCT02418585, NCT02493868.PMID:38557430 | DOI:10.1017/S1092852924000105 (Source: CNS Spectrums)
Source: CNS Spectrums - April 1, 2024 Category: Neurology Authors: Jennifer Kern Sliwa Ronaldo R Naranjo Ibrahim Turkoz Mary Pat Petrillo Patricia Cabrera Madhukar Trivedi Source Type: research
Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery- Åsberg Depression Rating Scale and the 9-item Patient Health Questionnaire
CONCLUSIONS: In adults with TRD, ESK + OAD significantly improved severity of depressive symptoms, and more patients achieved clinically meaningful changes in depressive symptoms based on PHQ-9, versus OAD + PBO. PHQ-9 outcomes were consistent with those of clinician-rated MADRS.TRIAL REGISTRATION: ClinicalTrials.gov: NCT02417064, NCT02418585, NCT02493868.PMID:38557430 | DOI:10.1017/S1092852924000105 (Source: CNS Spectrums)
Source: CNS Spectrums - April 1, 2024 Category: Neurology Authors: Jennifer Kern Sliwa Ronaldo R Naranjo Ibrahim Turkoz Mary Pat Petrillo Patricia Cabrera Madhukar Trivedi Source Type: research
Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery- Åsberg Depression Rating Scale and the 9-item Patient Health Questionnaire
CONCLUSIONS: In adults with TRD, ESK + OAD significantly improved severity of depressive symptoms, and more patients achieved clinically meaningful changes in depressive symptoms based on PHQ-9, versus OAD + PBO. PHQ-9 outcomes were consistent with those of clinician-rated MADRS.TRIAL REGISTRATION: ClinicalTrials.gov: NCT02417064, NCT02418585, NCT02493868.PMID:38557430 | DOI:10.1017/S1092852924000105 (Source: CNS Spectrums)
Source: CNS Spectrums - April 1, 2024 Category: Neurology Authors: Jennifer Kern Sliwa Ronaldo R Naranjo Ibrahim Turkoz Mary Pat Petrillo Patricia Cabrera Madhukar Trivedi Source Type: research
Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery- Åsberg Depression Rating Scale and the 9-item Patient Health Questionnaire
CONCLUSIONS: In adults with TRD, ESK + OAD significantly improved severity of depressive symptoms, and more patients achieved clinically meaningful changes in depressive symptoms based on PHQ-9, versus OAD + PBO. PHQ-9 outcomes were consistent with those of clinician-rated MADRS.TRIAL REGISTRATION: ClinicalTrials.gov: NCT02417064, NCT02418585, NCT02493868.PMID:38557430 | DOI:10.1017/S1092852924000105 (Source: CNS Spectrums)
Source: CNS Spectrums - April 1, 2024 Category: Neurology Authors: Jennifer Kern Sliwa Ronaldo R Naranjo Ibrahim Turkoz Mary Pat Petrillo Patricia Cabrera Madhukar Trivedi Source Type: research
Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery- Åsberg Depression Rating Scale and the 9-item Patient Health Questionnaire
CONCLUSIONS: In adults with TRD, ESK + OAD significantly improved severity of depressive symptoms, and more patients achieved clinically meaningful changes in depressive symptoms based on PHQ-9, versus OAD + PBO. PHQ-9 outcomes were consistent with those of clinician-rated MADRS.TRIAL REGISTRATION: ClinicalTrials.gov: NCT02417064, NCT02418585, NCT02493868.PMID:38557430 | DOI:10.1017/S1092852924000105 (Source: CNS Spectrums)
Source: CNS Spectrums - April 1, 2024 Category: Neurology Authors: Jennifer Kern Sliwa Ronaldo R Naranjo Ibrahim Turkoz Mary Pat Petrillo Patricia Cabrera Madhukar Trivedi Source Type: research
